David Cotnoir-White

David Cotnoir-White is a seasoned professional in the field of biotechnology, currently serving as the CEO and Co-Founder of Modulari-T Bio, where innovative approaches to cell therapy are being developed through structural and synthetic biology. In addition to this role, Cotnoir-White is a Venture Partner at Pioneer Fund. Previously, experiences include serving as an Associate Researcher at the Institut de recherches cliniques de Montréal, focusing on novel assays for neuroregenerative therapies, and a Postdoctoral Fellow at Université de Montréal, conducting research on small molecule libraries for potential Alzheimer's and Parkinson's disease therapies. Educational qualifications include a Ph.D. in Molecular Biology from Université de Montréal and a Master's degree in Structural Biology from McGill University, along with recent studies in Life Sciences Entrepreneurship Development at Concordia University and ongoing education at Y Combinator.